Srinivasvinod Saladi

Assistant Professor

Harvard Medical School

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Srinivasvinod Saladi is an Assistant Professor at Harvard Medical School in the United States. His research focuses on innovative approaches in cancer biology, including the development of fluorescent cellular probes and investigating immune checkpoint inhibitors in head and neck squamous cell carcinoma. He has contributed to studies on cellular regeneration and the role of specific genes and proteins in tumorigenesis and chemoresistance in various cancers.

Articles (11)

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

Assistant Professor

Massachusetts Eye and Ear, Harvard Medical School

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Srinivasvinod Saladi

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

NeoMProbe: a new class of fluorescent cellular and tissue membrane probe

Reprogramming by drug-like molecules leads to regeneration of cochlear hair cell–like cells in adult mice

First Clinical Results of Fluorescence Lifetime-enhanced Tumor Imaging Using Receptor-targeted Fluorescent Probes

Current and Future Biomarkers for Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma.

YAP1 maintains active chromatin state in head and neck squamous cell carcinomas that promotes tumorigenesis through cooperation with BRD4.

A unique subset of glycolytic tumour-propagating cells drives squamous cell carcinoma

RASAL2 Confers Collateral MEK/EGFR Dependency in Chemoresistant Triple-Negative Breast Cancer.

Essential role of the histone lysine demethylase KDM4A in the biology of malignant pleural mesothelioma (MPM).

Novel Therapeutic Targets and Immune Dysfunction in Malignant Pleural Mesothelioma.

RUVBL1 is an amplified epigenetic factor promoting proliferation and inhibiting differentiation program in head and neck squamous cancers

Inhibitors of the Transcription Factor STAT3 Decrease Growth and Induce Immune Response Genes in Models of Malignant Pleural Mesothelioma (MPM).

Collaborators (6)

Brian Lin

William Faquin

Caroline Chidley

Richard Joh

Eben Rosenthal

Artur Indzhykulian

Make your next move.